[Puget Sound Business Journal] $1,000-a-pill hepatitis C drug may be too costly for Medicaid insurers

By Atia Musazay
May 14, 2014


A breakthrough drug now on the market could be a potential cure for hepatitis C. But with its costly price tag of $1,000, or $84,000 for a 12-week treatment, the state of Washington is concerned that not everyone who needs the medication will be able to afford it.


Read More



Sign-up for updates

  • This field is for validation purposes and should be left unchanged.